A
EW icon

Allianz’s Edwards Lifesciences EW Stock Holding History

Allianz’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
2,490
-16,094
-87% -$1.35M ﹤0.01% 384
2026
Q1 		$1.49M Buy
18,584
+8,727
+89% +$719K 0.02% 262
2025
Q4 		$840K Buy
9,857
+7,367
+296% +$605K 0.01% 265
2025
Q3 		$194K Hold
2,490
– – ﹤0.01% 305
2025
Q2 		$195K Hold
2,490
– – ﹤0.01% 304
2025
Q1 		$180K Sell
2,490
-2,070
-45% -$148K ﹤0.01% 322
2024
Q4 		$339K Sell
4,560
-2,250
-33% -$157K 0.01% 290
2024
Q3 		$449K Buy
6,810
+5,410
+386% +$393K 0.01% 253
2024
Q2 		$129K Sell
1,400
-2,320
-62% -$205K ﹤0.01% 356
2024
Q1 		$355K Buy
+3,720
New +$312K 0.01% 283

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Allianz's EW Position: Q2 2026 in Review

Allianz reduced its Edwards Lifesciences (EW) stake by 87% in Q2 2026, selling an estimated $1.35M and leaving 2,490 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Allianz first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.49M in Q1 2026. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Allianz held 2,490 shares of Edwards Lifesciences worth $225K as of Q2 2026.
  • Allianz sold 16,094 Edwards Lifesciences shares in Q2 2026, an estimated $1.35M.
  • Edwards Lifesciences made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #384 holding.
  • Allianz first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Edwards Lifesciences position peaked at $1.49M in Q1 2026.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.